Decomplexation of Venom Proteome of Pakistani Cobra (Naja naja naja)
Decomplexation of Venom Proteome of Pakistani Cobra (Naja naja)
DOI:
https://doi.org/10.53560/PPASB(60-1)843Keywords:
Naja naja, Venom, Decomplexation, HPLC, SDS PAGEAbstract
The venom proteome of Naja naja from Sindh, Pakistan was decomplexed utilizing reverse phase HPLC and SDS PAGE. The results were compared with already reported Naja naja species of the region. The banding pattern represents all the major families of proteins including three-finger toxins, phospholipase A2, snake venom metalloproteases, L-amino acid oxidases, phosphodiesterase, nucleotidases, cysteine-rich secretory proteins, serine proteases, nerve growth factor, cobra venom factor, acetylcholinesterases, Kunitz-type serine protease inhibitors and C-type lectin proteins. The decomplexation of the venom showed the best possible separation through RP-HPLC elution of venom components containing small peptides, small and large proteins based on hydrophobicity. The SDS PAGE under reducing and non-reducing conditions of HPLC fractions highlighted the presence of several proteins.
References
C.H. Tan, K.Y. Tan, and N.H. Tan. 2019. A protein decomplexation strategy in snake venom proteomics. In: Methods in Molecular Biology; Springer, Clifton, NJ, USA, p.83-92 (2019).
M.S. Khan. A Guide to the Snakes of Pakistan. Edition Chimaira, Frankfurt am Main, Germany (2002).
M. Choudhury, R.J.R. McCleary, M. Kesherwani, R.M. Kini, and D. Velmurugan. Comparison of proteomic profiles of the venoms of two of the ‘Big Four’ snakes of India, the Indian cobra (Naja naja) and the common krait (Bungarus caeruleus), and analyses of their toxins. Toxicon 135: 33-42 (2017):
E. Alirol, S.K. Sharma, H.S. Bawaskar, U. Kuch, and F. Chappuis. Snake bite in South Asia: a review. PLoS neglected tropical diseases 4(1): e603 (2010).
A. Manuwar, B. Dreyer, A. Böhmert, A. Ullah, Z. Mughal, A. Akrem, S.A. Ali, , H. Schlüter, and C. Betzel. Proteomic investigations of two Pakistani Naja snake venom species unravel the venom complexity, posttranslational modifications, and presence of extracellular vesicles. Toxins 12(11): 669 (2020).
M.H. Asad, R.J. McCleary, I. Salafutdinov, FAlam, H.S. Shah, S. Bibi, A. Ali, S. Khalid, S.M. Hasan, J.M. Sabatier, and M.D. Waard. Proteomics study of Southern Punjab Pakistani cobra (Naja naja: Formerly Naja naja karachiensis) venom. Toxicological & Environmental Chemistry 101(1-2): 91-116 (2019).
U.K. Laemmli. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259): 680-685 (1970).
B. Lomonte, and J.J. Calvete. Strategies in ‘snake venomics’ aiming at an integrative view of compositional, functional, and immunological characteristics of venoms. Journal of Venomous Animals and Toxins including Tropical Diseases 23: 26 (2017).
Wong, K.Y., Tan, C.H., Tan, K.Y., Quraishi, N.H. and Tan, N.H., 2018. Elucidating the biogeographical variation of the venom of Naja naja (spectacled cobra) from Pakistan through a venom-decomplexing proteomic study. Journal of proteomics 175: 156-173.
K. Sintiprungrat, K. Watcharatanyatip, W.D.S.T. Senevirathne, P. Chaisuriya, D. Chokchaichamnankit, C. Srisomsap, and K. Ratanabanangkoon. A comparative study of venomics of Naja naja from India and Sri Lanka, clinical manifestations and antivenomics of an Indian polyspecific antivenom. Journal of Proteomics 132: 131-143 (2016).
M. Vanuopadath, D. Raveendran, B.G. Nair, and S.S. Nair. Venomics and antivenomics of Indian spectacled cobra (Naja naja) from the Western Ghats. Acta Tropica 228: 106324 (2022).
S.U. Hashmi, A. Alvi, I. Munir, M. Perveen, A. Fazal, T.N. Jackson, and S.A. Ali. Functional venomics of the Big-4 snakes of Pakistan. Toxicon 179: 60-71 (2020).
K.Y. Wong, K.Y. Tan, N.H. Tan, and C.H. Tan. A neurotoxic snake venom without phospholipase A2: Proteomics and cross-neutralization of the venom from Senegalese cobra, Naja senegalensis (Subgenus: Uraeus). Toxins 13(1): 60 (2021).
Downloads
Published
How to Cite
Issue
Section
License
Creative Commons Attribution (CC BY). Allows users to: copy the article and distribute; abstracts, create extracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation); include in a collective work (such as an anthology); and text or data mine the article. These uses are permitted even for commercial purposes, provided the user: includes a link to the license; indicates if changes were made; gives appropriate credit to the author(s) (with a link to the formal publication through the relevant DOI); and does not represent the author(s) as endorsing the adaptation of the article or modify the article in such a way as to damage the authors' honor or reputation.
